Works by Roepman, Paul


Results: 33
    1

    Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.

    Published in:
    Oncologist, 2024, v. 29, n. 5, p. 431, doi. 10.1093/oncolo/oyad320
    By:
    • Spiekman, Ilse A C;
    • Geurts, Birgit S;
    • Zeverijn, Laurien J;
    • Wit, Gijs F de;
    • van der Noort, Vincent;
    • Roepman, Paul;
    • Leng, Wendy W J de;
    • Jansen, Anne M L;
    • Kusters, Benno;
    • Beerepoot, Laurens V;
    • Vos, Filip Y F L de;
    • Groot, Derk-Jan A de;
    • Groot, Jan Willem B de;
    • Hoeben, Ann;
    • Buter, Jan;
    • Gelderblom, Hans A J;
    • Voest, Emile E;
    • Verheul, Henk M W
    Publication type:
    Article
    2

    Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.

    Published in:
    Molecular Oncology, 2015, v. 9, n. 6, p. 1218, doi. 10.1016/j.molonc.2015.02.006
    By:
    • Jansen, Maurice P.H.M.;
    • Sas, Leen;
    • Sieuwerts, Anieta M.;
    • Van Cauwenberghe, Caroline;
    • Ramirez-Ardila, Diana;
    • Look, Maxime;
    • Ruigrok-Ritstier, Kirsten;
    • Finetti, Pascal;
    • Bertucci, François;
    • Timmermans, Mieke M.;
    • van Deurzen, Carolien H.M.;
    • Martens, John W.M.;
    • Simon, Iris;
    • Roepman, Paul;
    • Linn, Sabine C.;
    • van Dam, Peter;
    • Kok, Marleen;
    • Lardon, Filip;
    • Vermeulen, Peter B.;
    • Foekens, John A.
    Publication type:
    Article
    3
    4
    5
    6

    Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE).

    Published in:
    BMC Medical Genomics, 2020, v. 13, n. 1, p. N.PAG, doi. 10.1186/s12920-020-00814-w
    By:
    • Samsom, Kris G.;
    • Bosch, Linda J. W.;
    • Schipper, Luuk J.;
    • Roepman, Paul;
    • de Bruijn, Ewart;
    • Hoes, Louisa R.;
    • Riethorst, Immy;
    • Schoenmaker, Lieke;
    • van der Kolk, Lizet E.;
    • Retèl, Valesca P.;
    • Frederix, Geert W. J.;
    • Buffart, Tineke E.;
    • van der Hoeven, Jacobus J. M.;
    • Voest, Emile E.;
    • Cuppen, Edwin;
    • Monkhorst, Kim;
    • Meijer, Gerrit A.
    Publication type:
    Article
    7
    8

    Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.

    Published in:
    BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10663-2
    By:
    • Geurts, Birgit S.;
    • Battaglia, Thomas W.;
    • van Berge Henegouwen, J. Maxime;
    • Zeverijn, Laurien J.;
    • de Wit, Gijs F.;
    • Hoes, Louisa R.;
    • van der Wijngaart, Hanneke;
    • van der Noort, Vincent;
    • Roepman, Paul;
    • de Leng, Wendy W. J.;
    • Jansen, Anne M. L.;
    • Opdam, Frans L.;
    • de Jonge, Maja J. A.;
    • Cirkel, Geert A.;
    • Labots, Mariette;
    • Hoeben, Ann;
    • Kerver, Emile D.;
    • Bins, Adriaan D.;
    • Erdkamp, Frans G.L.;
    • van Rooijen, Johan M.
    Publication type:
    Article
    9
    10

    RIP140 increases APC expression and controls intestinal homeostasis and tumorigenesis.

    Published in:
    Journal of Clinical Investigation, 2014, v. 124, n. 5, p. 1899, doi. 10.1172/JCI65178
    By:
    • Lapierre, Marion;
    • Bonnet, Sandrine;
    • Bascoul-Mollevi, Caroline;
    • Ait-Arsa, Imade;
    • Jalaguier, Stéphan;
    • Del Rio, Maguy;
    • Plateroti, Michela;
    • Roepman, Paul;
    • Ychou, Marc;
    • Pannequin, Julie;
    • Hollande, Frédéric;
    • Parker, Malcolm;
    • Cavailles, Vincent
    Publication type:
    Article
    11

    An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.

    Published in:
    2016
    By:
    • Wesseling, Jelle;
    • Tinterri, Corrado;
    • Sapino, Anna;
    • Zanconati, Fabrizio;
    • Lutke-Holzik, Martijn;
    • Nguyen, Bichlien;
    • Deck, Kenneth;
    • Querzoli, Patrizia;
    • Perin, Tiziana;
    • Giardina, Carmela;
    • Seitz, Gerhard;
    • Guinebretière, Jean-Marc;
    • Barone, Julie;
    • Dekker, Laura;
    • Snoo, Femke;
    • Stork-Sloots, Lisette;
    • Roepman, Paul;
    • Watanabe, Toru;
    • Cusumano, Pino;
    • Deck, Kenneth B
    Publication type:
    journal article
    12
    13

    Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice.

    Published in:
    Nature Protocols, 2024, v. 19, n. 3, p. 700, doi. 10.1038/s41596-023-00933-5
    By:
    • Samsom, Kris G.;
    • Bosch, Linda J. W.;
    • Schipper, Luuk J.;
    • Schout, Daoin;
    • Roepman, Paul;
    • Boelens, Mirjam C.;
    • Lalezari, Ferry;
    • Klompenhouwer, Elisabeth G.;
    • de Langen, Adrianus J.;
    • Buffart, Tineke E.;
    • van Linder, Berit M. H.;
    • van Deventer, Kelly;
    • van den Burg, Kay;
    • Unmehopa, Unga;
    • Rosenberg, Efraim H.;
    • Koster, Roelof;
    • Hogervorst, Frans B. L.;
    • van den Berg, José G.;
    • Riethorst, Immy;
    • Schoenmaker, Lieke
    Publication type:
    Article
    14
    15
    16
    17

    Tumor Profiling Turmoil.

    Published in:
    Cell Cycle, 2005, v. 4, n. 5, p. 659, doi. 10.4161/cc.4.5.1679
    By:
    • Roepman, Paul;
    • Holstege, Frank C. P.
    Publication type:
    Article
    18

    Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition.

    Published in:
    International Journal of Cancer, 2014, v. 134, n. 3, p. 552, doi. 10.1002/ijc.28387
    By:
    • Roepman, Paul;
    • Schlicker, Andreas;
    • Tabernero, Josep;
    • Majewski, Ian;
    • Tian, Sun;
    • Moreno, Victor;
    • Snel, Mireille H;
    • Chresta, Christine M;
    • Rosenberg, Robert;
    • Nitsche, Ulrich;
    • Macarulla, Teresa;
    • Capella, Gabriel;
    • Salazar, Ramon;
    • Orphanides, George;
    • Wessels, Lodewyk FA;
    • Bernards, Rene;
    • Simon, Iris M
    Publication type:
    Article
    19
    20
    21

    Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients.

    Published in:
    Cancers, 2022, v. 14, n. 2, p. 436, doi. 10.3390/cancers14020436
    By:
    • Schipper, Luuk J.;
    • Monkhorst, Kim;
    • Samsom, Kris G.;
    • Bosch, Linda J.W.;
    • Snaebjornsson, Petur;
    • van Boven, Hester;
    • Roepman, Paul;
    • van der Kolk, Lizet E.;
    • van Houdt, Winan J.;
    • van der Graaf, Winette T.A.;
    • Meijer, Gerrit A.;
    • Voest, Emile E.
    Publication type:
    Article
    22

    A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III Tumors.

    Published in:
    Cancers, 2021, v. 13, n. 17, p. 4449, doi. 10.3390/cancers13174449
    By:
    • Palassin, Pascale;
    • Lapierre, Marion;
    • Pyrdziak, Samuel;
    • Wagner, Antoine;
    • Stehle, Régine;
    • Corsini, Carole;
    • Duffour, Jacqueline;
    • Bonnet, Sandrine;
    • Boulahtouf, Abdelhay;
    • Rodriguez, Carmen;
    • Ho-Pun-Cheung, Alexandre;
    • Lopez-Crapez, Evelyne;
    • Boissière-Michot, Florence;
    • Bibeau, Frédéric;
    • Thezenas, Simon;
    • Elarouci, Nabila;
    • Selves, Janick;
    • Hoffmann, Jean-Sébastien;
    • Roepman, Paul;
    • Mazard, Thibault
    Publication type:
    Article
    23

    The consensus molecular subtypes of colorectal cancer.

    Published in:
    Nature Medicine, 2015, v. 21, n. 11, p. 1350, doi. 10.1038/nm.3967
    By:
    • Guinney, Justin;
    • Dienstmann, Rodrigo;
    • Wang, Xin;
    • de Reyniès, Aurélien;
    • Schlicker, Andreas;
    • Soneson, Charlotte;
    • Marisa, Laetitia;
    • Roepman, Paul;
    • Nyamundanda, Gift;
    • Angelino, Paolo;
    • Bot, Brian M;
    • Morris, Jeffrey S;
    • Simon, Iris M;
    • Gerster, Sarah;
    • Fessler, Evelyn;
    • De Sousa E Melo, Felipe;
    • Missiaglia, Edoardo;
    • Ramay, Hena;
    • Barras, David;
    • Homicsko, Krisztian
    Publication type:
    Article
    24
    25
    26

    Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.

    Published in:
    PharmacoEconomics, 2021, v. 39, n. 12, p. 1429, doi. 10.1007/s40273-021-01073-y
    By:
    • Simons, Martijn J. H. G.;
    • Retèl, Valesca P.;
    • Ramaekers, Bram L. T.;
    • Butter, Rogier;
    • Mankor, Joanne M.;
    • Paats, Marthe S.;
    • Aerts, Joachim G. J. V.;
    • Mfumbilwa, Zakile A.;
    • Roepman, Paul;
    • Coupé, Veerle M. H.;
    • Uyl-de Groot, Carin A.;
    • van Harten, Wim H.;
    • Joore, Manuela A.
    Publication type:
    Article
    27

    Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D‐CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.

    Published in:
    International Journal of Cancer, 2023, v. 153, n. 7, p. 1413, doi. 10.1002/ijc.34649
    By:
    • Zeverijn, Laurien J.;
    • Looze, Eleonora J.;
    • Thavaneswaran, Subotheni;
    • van Berge Henegouwen, J. Maxime;
    • Simes, Robert J.;
    • Hoes, Louisa R.;
    • Sjoquist, Katrin M.;
    • van der Wijngaart, Hanneke;
    • Sebastian, Lucille;
    • Geurts, Birgit S.;
    • Lee, Chee K.;
    • de Wit, Gijsbrecht F.;
    • Espinoza, David;
    • Roepman, Paul;
    • Lin, Frank P.;
    • Jansen, Anne M. L.;
    • de Leng, Wendy W. J.;
    • van der Noort, Vincent;
    • Leek, Lindsay V. M.;
    • de Vos, Filip Y. F. L.
    Publication type:
    Article
    28
    29
    30

    Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.

    Published in:
    Journal of Pathology, 2024, v. 263, n. 3, p. 288, doi. 10.1002/path.6279
    By:
    • Geurts, Birgit S;
    • Zeverijn, Laurien J;
    • van Berge Henegouwen, Jade M;
    • van der Wijngaart, Hanneke;
    • Hoes, Louisa R;
    • de Wit, Gijs F;
    • Spiekman, Ilse AC;
    • Battaglia, Thomas W;
    • van Beek, Daphne M;
    • Roepman, Paul;
    • Jansen, Anne ML;
    • de Leng, Wendy WJ;
    • Broeks, Annegien;
    • Labots, Mariette;
    • van Herpen, Carla ML;
    • Gelderblom, Hans;
    • Verheul, Henk MW;
    • Snaebjornsson, Petur;
    • Voest, Emile E
    Publication type:
    Article
    31

    Feasibility of whole‐genome sequencing‐based tumor diagnostics in routine pathology practice.

    Published in:
    Journal of Pathology, 2022, v. 258, n. 2, p. 179, doi. 10.1002/path.5988
    By:
    • Samsom, Kris G;
    • Schipper, Luuk J;
    • Roepman, Paul;
    • Bosch, Linda JW;
    • Lalezari, Ferry;
    • Klompenhouwer, Elisabeth G;
    • de Langen, Adrianus J;
    • Buffart, Tineke E;
    • Riethorst, Immy;
    • Schoenmaker, Lieke;
    • Schout, Daoin;
    • van der Noort, Vincent;
    • van den Berg, Jose G;
    • de Bruijn, Ewart;
    • van der Hoeven, Jacobus JM;
    • van Snellenberg, Hans;
    • van der Kolk, Lizet E;
    • Cuppen, Edwin;
    • Voest, Emile E;
    • Meijer, Gerrit A
    Publication type:
    Article
    32

    Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing.

    Published in:
    Journal of Pathology, 2013, v. 230, n. 3, p. 270, doi. 10.1002/path.4209
    By:
    • Majewski, Ian J;
    • Mittempergher, Lorenza;
    • Davidson, Nadia M;
    • Bosma, Astrid;
    • Willems, Stefan M;
    • Horlings, Hugo M;
    • de Rink, Iris;
    • Greger, Liliana;
    • Hooijer, Gerrit KJ;
    • Peters, Dennis;
    • Nederlof, Petra M;
    • Hofland, Ingrid;
    • de Jong, Jeroen;
    • Wesseling, Jelle;
    • Kluin, Roelof JC;
    • Brugman, Wim;
    • Kerkhoven, Ron;
    • Nieboer, Frank;
    • Roepman, Paul;
    • Broeks, Annegien
    Publication type:
    Article
    33